Close Menu

NEW YORK (GenomeWeb) – Claritas Genomics announced today that it has received New York State (NYS) Department of Health approval for its bone marrow failure, hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS), and nephrotic syndrome region of interest tests, as well as a mitochondrial DNA assay.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.